Cargando…
Incretin Therapy and Islet Pathology: A Time for Caution
Autor principal: | Kahn, Steven E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712079/ https://www.ncbi.nlm.nih.gov/pubmed/23596147 http://dx.doi.org/10.2337/db13-0520 |
Ejemplares similares
-
Incretin Therapy and Pancreatic Pathologies: Background Pathology Versus Drug-Induced Pathology in Rats
por: Egan, Josephine M., et al.
Publicado: (2014) -
Incretin concept revised: The origin of the insulinotropic function of glucagon‐like peptide‐1 – the gut, the islets or both?
por: Yabe, Daisuke, et al.
Publicado: (2017) -
The overdiagnosis nightmare: a time for caution
por: Ciatto, Stefano
Publicado: (2009) -
Ghrelin: A New Incretin Enhancer Therapy?
por: DeMarco, Vincent G., et al.
Publicado: (2015) -
Incretin action on bone: An added benefit?
por: Ma, Ronald C W, et al.
Publicado: (2015)